On-demand webinar

Collateral Effects of
COVID-19 on Stroke Imaging

Collateral Effects of COVID-19 Webinar

Currently, the world is approaching the ten million mark for total cumulative COVID-19 cases. In May, an independent research study using real-time imaging data from more than 800 hospitals in the U.S. reported a nearly 40% decline in imaging to evaluate stroke patients during the COVID-19 pandemic. Please join lead researcher, Dr. Akash P. Kansagra, Assistant Professor of Radiology, Neurological Surgery, and Neurology at the Washington University School of Medicine, for a presentation on his findings published in The New England Journal of Medicine and the importance of real-time data derived from RapidAI Insights.

Duration: 30 minutes

THIS SESSION WILL COVER

  • Collateral effects of COVID-19 on acute ischemic stroke
  • Real-time data utilization and its impact
  • What is RapidAI Insights and what value it can bring to clinicians and researchers
  • Q&A  

 

SPEAKER

Dr. Kansagra

Akash Kansagra, MD, MS

Assistant Professor of Radiology, Neurological Surgery, and Neurology; Director, Endovascular Surgical Neuroradiology; Co-Director, Stroke and Cerebrovascular Center Washington University School of Medicine and Barnes-Jewish Hospital.

VIEW THE WEBINAR
Excerpts from Webinar:
Is COVID-19 a real risk factor for stroke? 

We don't know the answer to that yet. We kind of view COVID research and stroke in two different camps. There is research about the link between COVID and stroke which many groups are well-positioned to answer. Then there's the other question of all these collateral effects, and that's where we need that national data as we have from this study. So this study is better poised to answer the question about overall stroke care delivery. In terms of the direct link between COVID and stroke, that will likely come from other sources.

Have stroke transfer protocols changed due to COVID?

We have not changed our transfer protocols aside from mandating PPE. If anything, our mission has been that this data has focused our test not to change how transport is done, but really to emphasize the need for transport to continue happening. Most of our patients don't have COVID, but COVID patients can have a stroke. So we have been really laser-focused on making sure that those patients continue to receive the care they need.

Has the COVID-19 pandemic changed how stroke patients are treated? 

This research has not changed how to treat stroke patients with or without COVID. In fact, the whole message that this data has reinforces the need to continue showing up and doing the thing that we have always been doing, which is providing a standard of care and stroke therapies. The real harm has come from the countless victims of stroke that were treated differently than they might have been in January or February, just because they happen to have a stroke around the time of the pandemic.

 

©2008-2024 iSchemaView, Inc. | Privacy Policy